Tumor Ablation Market By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Other Technologies), By Treatment (Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation), By Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, Other Application) – Growth, Future Prospects And Competitive Analysis 2015 – 2025

Market Insights

Tumor ablation is a minimally invasive surgical procedure used to treat solid cancers. Factors such as the rising prevalence of different forms of cancer, technological advancements in the field of ablation, rising awareness regarding the benefits offered by ablation procedures over conventional surgical procedures, and a rising number of hospitals, surgical centers, and ablation centers are driving the growth of the tumor ablation market globally.

The report titled “Tumor Ablation Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall tumor ablation market, along with the market size and estimates for the duration of 2015–2025. The research study covers an in-depth analysis of market segments based on technology (radiofrequency ablation, microwave ablation, cryoablation, and other technologies), treatment (surgical ablation, laparoscopic ablation, and percutaneous ablation), application (liver cancer, lung cancer, kidney cancer, bone metastasis, and other applications), and different geographical regions.

Geographically, the global tumor ablation market is studied for the following regional markets:

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global tumor ablation market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive landscape of the global tumor ablation market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global tumor ablation market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report. Thus, the research study provides a holistic view of the global tumor ablation market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on technology, the global tumor ablation market is segmented as follows:

• Radiofrequency ablation
• Microwave ablation
• Cryoablation
• Other Technology

Tumor ablation is a minimally invasive surgical procedure used to treat solid cancers. Special probes are used to burn or freeze tumors without performing conventional surgery. These treatments are also given to patients who are awaiting a liver transplant. Factors such as the rising prevalence of different forms of cancer, the growing number of hospitals, surgical and ablation centers, technological advancements in ablation devices, and the growing adoption of tumor ablation procedures are driving the growth of the tumor ablation market globally. It is observed that in the base year 2016, radiofrequency ablation held the largest market share, and it is anticipated that it will grow at the highest CAGR during the forecast period due to factors such as less risk of tissue damage, a widely accepted method for small tumors, and faster recovery that will influence the growth of the radiofrequency ablation market globally. Radiofrequency ablation is commonly used to treat cancer in the bone, kidney, liver, lung, and prostate.

Based on treatment, the global tumor ablation market is segmented as follows:

• Surgical ablation
• Laparoscopic ablation
• Percutaneous ablation

Ablation refers to the removal of tissue from the body; tumor ablation is a minimally invasive surgical procedure used to treat solid cancers. Special probes are used to burn or freeze tumors without the usual surgery. Factors such as the increasing prevalence of different forms of cancer, rising demand for minimally invasive procedures, technological advancements in the field of ablation, and a rising number of hospitals and surgical and ablation centers are driving the growth of the tumor ablation market globally. It is observed that in the base year 2016, surgical ablation held the largest market share due to factors such as the rising prevalence of liver and breast cancer and the increasing use of thoracoscopic surgical ablation, which are fueling the growth of the surgical ablation market worldwide. There are different types of ablations, and various techniques are used to perform the removal of tissue, depending on the nature of the issue. Surgical ablation may be performed with a laser, or radio frequency emissions may be used.

Based on application, the global tumor ablation market is segmented as follows:

• Liver cancer
• Lung cancer
• Kidney cancer
• Bone metastasis
• Other applications

Tumor ablation is a minimally invasive procedure that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung. Special probes are used to burn or freeze tumors without the usual surgery; these treatments are also sometimes performed in patients waiting for a liver transplant. Factors such as the rising prevalence of different forms of cancer, technological advancements in ablation devices, and the growing adoption of tumor ablation procedures are driving the growth of the tumor ablation market globally. It is observed that, in the base year 2016, liver cancer was the largest revenue-generating segment because of the increase in the prevalence of the disease and because tumor ablation is a globally accepted procedure in the treatment of solid tumors in the liver for patients where surgery is not possible or preferred. Tumor ablation is also sometimes performed in patients waiting for a liver transplant. Radiofrequency ablation is used primarily to shrink or slow down the growth of liver carcinoma; it is usually done as an outpatient procedure under light sedation.

For the purpose of this study, the global tumor ablation market is categorized into three segments:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

In the base year 2016, North America dominated the tumor ablation market in terms of revenue, and it is anticipated that it will show significant growth during the forecast period. The U.S. was observed as the largest country-level market in North America. Factors such as the increasing prevalence of different forms of cancer, advanced healthcare infrastructure, higher cost of therapy, technological advances, and increased government funding are the prime contributors to the dominance of North America. It is anticipated that Asia Pacific will grow at the highest CAGR during the forecast period due to developing economic conditions, improved treatment access, an improvement in awareness among the general patient population, rising medical expenditures in emerging economies such as India, China, and Japan, and the growing market penetration of major players in this region, which will drive the market growth in Asia Pacific during the forecast period 2017-2025.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Tumor Ablation Market Snapshot
2.2 Global Tumor Ablation Market, by Technology, 2016 (US$ Bn)
2.3 Global Tumor Ablation Market, by Treatment, 2016 (US$ Bn)
2.4 Global Tumor Ablation Market, by Application, 2016 (US$ Bn)
2.5 Global Tumor Ablation Market Share, by Geography, 2016 (Value %)

Chapter 3 Tumor Ablation Market Analysis
3.1 Global Tumor Ablation Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Increase in demand for minimally invasive cancer procedures
3.2.1.2 Rising prevalence of cancer
3.2.2 Challenges
3.2.2.1 Stringent Regulatory Guidelines
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Tumor Ablation Market

Chapter 4 Global Tumor Ablation Market, by Technology
4.1 Overview
4.2 Radiofrequency ablation
4.3 Microwave ablation
4.4 Cryoablation
4.5 Other technologies

Chapter 5 Global Tumor Ablation Market, by Treatment
5.1 Overview
5.2 Surgical ablation
5.3 Laparoscopic ablation
5.4 Percutaneous ablation

Chapter 6 Global Tumor Ablation Market, by Application
6.1 Overview
6.2 Liver cancer
6.3 Lung Cancer
6.4 Kidney Cancer
6.5 Bone metastasis
6.6 Other Application

Chapter 7 Global Tumor Ablation Market, By Geography
7.1 Preface
7.2 North America (U.S. & Canada)
7.3 Europe (U.K., Germany & Rest of Europe)
7.4 Asia Pacific (China, Japan and Rest of APAC)
7.5 Latin America
7.6 Middle East and Africa

Chapter 8 Company Profiles
8.1 Angiodynamics, Inc.
8.2 Boston Scientific Corp.
8.3 BVM Medical Limited
8.4 EDAP TMS S.A.
8.5 Galil Medical, Inc.
8.6 Healthtronics, Inc.
8.7 INTIO Inc.
8.8 Medtronic, Plc.
8.9 Mermaid Medical, Inc.
8.10 Mesonix, Inc.
8.11 Neuwave Medical, Inc.
8.12 Sonacare Medical, LLC

List of Figures

FIG. 1 Tumor Ablation Market: Research Methodology
FIG. 2 Global Tumor Ablation Market, by Technology, 2016 (US$ Bn)
FIG. 3 Global Tumor Ablation Market, by Treatment, 2016 (US$ Bn)
FIG. 4 Global Tumor Ablation Market, by Application, 2016 (US$ Bn)
FIG. 5 Global Tumor Ablation Market Share, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition: Global Tumor Ablation Market, by Geography, 2016
FIG. 7 Global Radiofrequency ablation Market for Tumor Ablation, 2015 – 2025 (US$ Bn)
FIG. 8 Global Microwave ablation Market for Tumor Ablation, 2015 – 2025 (US$ Bn)
FIG. 9 Global Cryoablation Market for Tumor Ablation, 2015 – 2025 (US$ Bn)
FIG. 10 Global Other technologies Market for Tumor Ablation, 2015 – 2025 (US$ Bn)
FIG. 11 Global Tumor Ablation Market for Surgical ablation, 2015 – 2025 (US$ Bn)
FIG. 12 Global Tumor Ablation Market for Laparoscopic ablation, 2015 – 2025 (US$ Bn)
FIG. 13 Global Tumor Ablation Market for Percutaneous ablation, 2015 – 2025 (US$ Bn)
FIG. 14 Global Tumor Ablation Market for Liver cancer, 2015 – 2025 (US$ Bn)
FIG. 15 Global Tumor Ablation Market for Lung Cancer, 2015 – 2025 (US$ Bn)
FIG. 16 Global Tumor Ablation Market for Kidney Cancer, 2015 – 2025 (US$ Bn)
FIG. 17 Global Tumor Ablation Market for Bone metastasis, 2015 – 2025 (US$ Bn)
FIG. 18 Global Tumor Ablation Market for Other Application, 2015 – 2025 (US$ Bn)
FIG. 19 Latin America Tumor Ablation Market, 2015 – 2025 (US$ Bn)
FIG. 20 Middle East and Africa Tumor Ablation Market, 2015 – 2025 (US$ Bn)

List of Tables

TABLE 1 Market Positioning of Key Players in Global Tumor Ablation Market
TABLE 2 Global Tumor Ablation Market, by Technology, 2015 – 2025 (US$ Bn)
TABLE 3 Global Tumor Ablation Market, by Treatment, 2015 – 2025 (US$ Bn)
TABLE 4 Global Tumor Ablation Market, by Application, 2015 – 2025 (US$ Bn)
TABLE 5 Global Tumor Ablation Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 6 North America Tumor Ablation Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 7 Europe Tumor Ablation Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 8 Asia Pacific Tumor Ablation Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 9 Angiodynamics, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 10 Boston Scientific Corp.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 11 BVM Medical Limited: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 12 EDAP TMS S.A.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 13 Galil Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 14 Healthtronics, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 15 INTIO Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 Medtronic, Plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 17 Mermaid Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 18 Mesonix, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 19 Neuwave Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 20 Sonacare Medical, LLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)